World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
![](/report_cover/2215/leading_cancer_diagnostics_market_players_strategic_assessments_of_major_suppliers_n_emerging_market_entrants_en.gif)
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 80 pages
Contains 80 pages
- Abbott
- AdnaGen
- Agensys
- Altana
- Ambrilia Biopharma
- AMDL
- BD
- Beckman Coulter
- Biofield
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- Biotrol/B. Braun
- CeMines
- Cepheid
- CIS/BIO
- Cliniqa
- Correlogic Systems
- Cytyc
- Daiichi
- DakoCytomation
- diaDexus
- DiagnoCure
- Diagnostic Systems
- Dianon
- DiaSorin
- Digene
- Eiken
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Gen-Probe
- Gene Logic
- Green Cross
- Grifols-Quest
- Guided Therapeutics
- Ibex Technologies
- Immunicon
- Ipsogen
- Kyowa Medex
- Matritech
- Molecular Diagnostics
- Myriad Genetics
- Nippon Flour Mills
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Quest Diagnostics Nichols Institute
- Roche Diagnostics
- Scantibodies
- Siemens
- Targeted Diagnostics
- Tosoh
- Trylon
- Wako Chemicals
- Worldwide Medical
- Zila